‘We care… because care is growth’. The low-tech imaginaries of India's small-scale pharmaceutical enterprises

Rault-Chodankar, Yves-Marie

doi:10.1016/j.ssmqr.2022.100144

Cited by 2 publications

(1 citation statement)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Based on the author's interview with 66 small enterprises, he found that India's small-scale entrepreneurs see themselves as instrumental to their family's financial welfare and the economic development of their local social group. Chodankar also found that Indian firms do not aim at saving the world through high-tech pharmaceuticals but are looking to build financially sustainable, low-risk firms that can provide a stable income for themselves and their families [7].…”

Section: An Analysis Of the Indian Pharmaceutical Industry's Characte...mentioning

confidence: 99%

ANALYZING the Impact of Product Patent Introduction: A trilateral study of the US, Japan and India

MITSUMORI,

GURTOO

2023

Int J Jpn Assoc Mgt Sys

View full text Add to dashboard Cite

India has strong pharmaceutical industry, which is unusual for a developing country. According to the IBEF, India ranks 3 rd worldwide for pharmaceutical production by volume and 14 th by value. Due to the WTO's TRIPS, India reintroduced product patents in the pharmaceutical field in 2005. Foreseeing the introduction of product patents in India, large pharmaceutical companies started NCE development around 2000. According to one previous study, Indian pharmaceutical firms had more than 200 molecules in the pipeline by 2015. However, so far, only a fraction of this has been launched. In contrast, the Japanese pharmaceutical industry has been developing rapidly since the country introduced product patents in 1976. This study explores the cause of this striking difference between Japan and India. Using a commercial database, it examines the patent filing activities of India and Japan. As a reference, an analysis on the U.S. was added to this study. The results of this study will help other developing countries to work out the pharmaceutical industry's strategies and tactics.

show abstract

Section: An Analysis Of the Indian Pharmaceutical Industry's Characte...mentioning

confidence: 99%

ANALYZING the Impact of Product Patent Introduction: A trilateral study of the US, Japan and India

MITSUMORI,

GURTOO

2023

Int J Jpn Assoc Mgt Sys

View full text Add to dashboard Cite

show abstract

Domestiquer la norme mondiale. Brevet pharmaceutique, bonnes pratiques de fabrication et contrôle du prix des médicaments en Inde

Rault-Chodankar¹

2022

espacepolitique

View full text Add to dashboard Cite

‘We care… because care is growth’. The low-tech imaginaries of India's small-scale pharmaceutical enterprises

Cited by 2 publications

References 22 publications

ANALYZING the Impact of Product Patent Introduction: A trilateral study of the US, Japan and India

ANALYZING the Impact of Product Patent Introduction: A trilateral study of the US, Japan and India

Domestiquer la norme mondiale. Brevet pharmaceutique, bonnes pratiques de fabrication et contrôle du prix des médicaments en Inde

Contact Info

Product

Resources

About